Combining intermediate levels of the Endotoxin Activity Assay (EAA) with other biomarkers in the assessment of patients with sepsis: Results of an observational study

Critical Care

Volumn 16, Issue 3, 2012, Pages

  Yaguchi, Arino ^a   Yuzawa, Junji ^a   Klein, David J ^b   Takeda, Munekasu ^a   Harada, Tomoyuki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOTOXIN; PROCALCITONIN;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CLINICAL PRACTICE; ENDOTOXIN ACTIVITY ASSAY; ENDOTOXIN DETECTION; FEMALE; GRAM NEGATIVE SEPSIS; HUMAN; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; BLOOD; HOSPITAL INFORMATION SYSTEM; MIDDLE AGED; SEPSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; ENDOTOXINS; FEMALE; HUMANS; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; RETROSPECTIVE STUDIES; SEPSIS;

EID: 84861126170     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11350     Document Type: Article

References (19)

1. Romaschin AD, Harris DM, Ribeiro MB, Paice J, Foster DM, Walker PM, Marshall JC. A rapid assay of endotoxin in whole blood using autologous neutrophil dependent chemiluminescence. J Immunol Methods 1998, 212:169-185. 10.1016/S0022-1759(98)00003-9, 9672205.
2. Romaschin AD, Foster DM, Walker PM, Marshall JC. Let the cells speak: neutrophils as biologic markers of the inflammatory response. Sepsis 1998, 2:119-125.
3. Mrashall JC, Walker PM, Foster DM, Harris D, Ribeiro M, Paice J, Romaschin AD, Derzko AN. Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Crit Care 2002, 6:342-348. 10.1186/cc1522, 125316, 12225611.
4. Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, Opal S, Abraham E, Brett SJ, Smith T, Mehta S, Derzko A, Romaschin A. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 2004, 190:527-534. 10.1086/422254, 15243928.
5. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson T, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327. 10.1097/01.CCM.0000298158.12101.41, 18158437.
6. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, . SCCM/ESICM/ACCP/ATS/SIS 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256. 10.1097/01.CCM.0000050454.01978.3B, 12682500, SCCM/ESICM/ACCP/ATS/SIS.
7. Klempner MS, Gallin JI. Inhibition of neutrophil Fc receptor function by corticosteroids. Clin Exp Immunol 1978, 34:137-142. 1537461, 750117.
8. Balk RA. Endotoxemia in critically ill patients: why a reliable test could be beneficial. Crit Care 2002, 6:289-290. 10.1186/cc1511, 137306, 12225599.
9. Murayama H, Oryoji T, Kiyonaga N, Tashiro S, Imabayashi T, Yasuda T, Kanmura Y. Newly developed endotoxin measurement method (endotoxin acitivity assay) may reflect the severity of sepsis. Crit Care 2009, 13(Suppl 1):381.
10. Valenza F, Fagnani L, Coppola S, Froio S, Tedesco C, Marenghi C, Galbusera C, Caironi P, Gattinoni L. Prevalence of endotoxemia in a population of patients admitted to an intensive care unit after elective surgery. Crit Care 2007, 11(Suppl 2):46.
11. Klein DJ, Derzko A, Foster D, Seely AJ, Brunet F, Romaschin AD, Marshall JC. Daily variation in endotoxin levels is associated with increased organ failure in critically ill patients. Shock 2007, 28:524-529.
12. Novelli G, Ferretti G, Ruberto F, Morabito V, Pugliese F. Early management of endotoxemia using the endotoxin activity assay and polymyxin B-based hemoperfusion. Contrib Nephrol 2010, 167:91-101.
13. Monti G, Bottiroli M, Pizzilli G, Minnini M, Terzi V, Vecchi I, Gesu G, Brioschi P, Vesconi S, Casella G. Endotoxin activity level and septic shock: a possible role for specific anti-endotoxin therapy?. Contrib Nephrol 2010, 167:102-110.
14. Klein D, Derzko A, Seely A, Foster D, Marshall J. Marker or mediator? Changes in endotoxin activity as a predictor of adverse outcomes in critical illness. Crit Care 2005, 9(Suppl 1):161.
15. Othman M, Aguero R, Lin HC. Alterations in intestinal microbial flora and human disease. Curr Opin Gastroenterol 2008, 24:11-16. 10.1097/MOG.0b013e3282f2b0d7, 18043226.
16. Cicalese L, Sileri P, Green M, Abu-Elmagd K, Fung JJ, Starzl TE, Reyes J. Bacterial translocation in clinical intestinal transplantation. Transplant Proc 2000, 32:1210. 10.1016/S0041-1345(00)01189-1, 3032597, 10995912.
17. Nieves E, Tobón LF, Ríos DI, Isaza A, Ramírez M, Beltrán JA, Garzón-Ospina D, Patarroyo MA, Gómez A. Bacterial translocation in abdominal trauma and postoperative infections. J Trauma 2011, 71:1258-1261. 10.1097/TA.0b013e318215140e, 21502873.
18. Foster D, Romaschin A, Derzko A, Walker P. Rates of agreement of endotoxin, procalcitonin and lactate in septic and non-septic critically ill patients. Crit Care 2005, 9(Suppl 1):162.
19. Otero R, Crawford J, Suarez A, Rivers E, Yang J. Correlation of endotoxin, procalsitonin and C-reactive peptide pattern with ICU admission. Crit Care 2008, 12(Suppl 2):189. 10.1186/cc6410, 2646338, 19090977.